Wild-type p53-induced apoptosis in a Burkitt lymphoma cell line is inhibited by interferon gamma

International Journal of Cancer

Volumn 67, Issue 1, 1996, Pages 106-112

  Sangfelt, Olle ^a   Einhorn, Stefan ^a   Björklund, Ann Charlotte ^a   Wiman, Klas G ^a   Okan, Ismail ^a   Grandér, Dan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; ONCOPROTEIN; PROTEIN BAX; PROTEIN P53; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GAMMA INTERFERON;

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BURKITT LYMPHOMA; HUMANS; INTERFERON TYPE II; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030038299     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960703)67:1<106::AID-IJC18>3.0.CO;2-C     Document Type: Article

References (29)

1. ALONI-GRINSTEIN, R., ZAN-BAR, I., ALBOUM, I., GOLDFINGER, N. and ROTTER, V., Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage. Oncogene, 8, 3297-3305 (1993).
2. DEISS, L.P., FEINSTEN, E., BERISSI, H., COHEN, O. and KIMCHI, A., Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the γ-interferon-induced cell death. Genes Devel., 9, 15-30 (1995).
3. DE MAYER, E. and DE MAYER-GUIGNARD, J., Interferons and other regulatory cytokines. Wiley, New York (1988).
4. DONEHOWER, L.A. and BRADLEY, A., The tumor suppressor p53. Biochem. biophys. Acta, 1155, 181-205 (1993).
5. EHINGER, M., NILSSON, E., PERSSON, A.-M., OLSSON, I. and GULLBERG, U., Involvement of the tumor supressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562. Cell Growth Differ, 6, 9-17 (1995).
6. EINHORN, S. and STRANDER, H., Interferon treatment of human malignancies-a short review. Med. Oncol. Tumor Pharmacother., 10, 25-29 (1993).
7. EL-DEIRY, W.S., TORINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, E., KINZLER, K.W. and VOGELSTEIN, B., WAFI, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
8. EVAN, G.I., WYLLIE, A.H., GILBERT, C.S., LITTLEWOOD, T.D., LAND, H., BROOKS, M., WATERS, C.M., PENN, L.Z. and HANCOCK, D.C., Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128 (1992).
9. GAVRIELI, Y., SHERMAN, Y. and BEN-SASSON, S.A., Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J. Cell Biol., 119, 493-501 (1992).
10. GRANDÉR, D., ÖBERG, K., LUNDOVIST, M.-L., TIENSUU JANSSON, E., ERIKSSON, B. and EINHORN, S., Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours. Lancet, 336, 337-340 (1990).
11. GRANDÉR, D., Xu, B. and EINHORN, S., Cytotoxic effect of interferon on primary malignant tumor cells. Studies in various malignancies. Europ. J. Cancer, 14, 1940-1943 (1993).
12. 1 growth arrest and apoptosis. Blood, 85, 2691-2698 (1995).
13. HITMAN, M., GRANDÉR, D., BRÖNDUM-NIELSEN, K., CEDERBLAD, B., LIU, Y., Xu, B. and EINHORN, S., Interferon system defects in malignant T-cells. Leukemia, 8, 425-434 (1994).
14. JEWELL, A.P., WORMAN, C.P., LYDYARD, P.M., YONG, K.L., GILES, F.J. and GOLDSTONE, A.H., Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Brit. J. Haematol., 88, 268-274 (1994).
15. KUERBITZ, S.J., PLUNKETT, B.S., WALSH, W.V. and KASTAN, M.B., Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. nat. Acad. Sci. (Wash.), 89, 7491-7495 (1992).
16. LOWE, S.W., SCHMITT, E.M., SMITH, S.W., OSBORNE, B.A. and JACKS, T., p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362, 847-849 (1993).
17. MICHALOVITZ, D., HALEVY, O. and OREN, M., Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell, 62, 671-680 (1990).
18. MILNER, A.E., GRAND, R.J.A. and GREGORY, C.D., Effects of interferon-α on human B cells: repression of apoptosis and prevention of cell growth are independent responses of Burkitt lymphoma lines. Int. J. Cancer, 61, 348-354 (1995).
19. MILNER, A.E., GRAND, R.J.A., WATERS, C.M. and GREGORY, C.D., Apoptosis in Burkitt lymphoma cells is driven by c-myc. Oncogene, 8, 3385-3391 (1993).
20. MIYASHITA, T. and REED, J.C., Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell, 80, 293-299 (1995).
21. PORWIT-MACDONALD, A., IVORY, K., WILKINSON, S., WHEATLEY, K., WONG, L. and JANOSSY, G., Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia. Leukemia, 9, 1191-1198 (1995).
22. RAMQVIST, T., MAGNUSSON, K.P., WANG, Y., SZEKELY, L., KLEIN, G. and WIMAN, K.G., Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) cell line that carries mutant p53. Oncogene, 8, 1495-1500 (1993).
23. L protects cancer cells from p53-mediated apoptosis. Oncogene, 11, 1389-1394 (1995).
24. TRUBIANI, O., BOSCO, D. and DI-PRIMIO, R., Interferon-gamma (IFN-gamma) induces programmed cell death in differentiated human leukemic B-cell lines. Exp. Cell Res., 215, 23-27 (1994).
25. VOGELSTEIN, B. and KINZLER, K.W., p53 function and dysfunction. Cell, 70, 523-526 (1992).
26. wafl/cipl. Genes Devel., 8, 2817-2830 (1994).
27. WANG, Y., SZEKELY, L., OKAN, I., KLEIN, G. and WIMAN, K.G., Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-mycinduced T-cell lymphoma line. Oncogene, 8, 3427-3431 (1993).
28. Wu, X. and LEVINE, A.J., p53 and E2F-1 cooperate to mediate apoptosis. Proc. nat. Acad. Sci. (Wash.), 91, 3602-3606 (1994).
29. YoNISH-ROUACH, E., RESNITZKY, D., LOTEM, J., SACHS, L., KIMCHI, A. and OREN, M., Wild-type p53 induces apoptosis of myeloid cells that is inhibited by interleukin-6. Nature (Lond.), 352, 345-347 (1991).